Abstract
Preterm births are prevalent and a leading cause of neonatal death in the United States. Despite the availability of effective interventions, to date there is not a robust and widely applicable test to identify pregnancies at high risk for spontaneous preterm birth (sPTB). Previously, a sPTB predictor based on the ratio of two proteins, IBP4/SHBG, was validated as an accurate predictor of sPTB in the observational study Proteomic Assessment of Preterm Risk (PAPR). Here it is demonstrated that the same predictor threshold associated with 2-fold increased risk of sPTB, namely −1.4, is also statistically significant for predicting elevated risk of sPTB in the observational study Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor (TreeToP).
Competing Interest Statement
Authors are employees or consultants to Sera Prognostics.
Clinical Trial
NCT02787213 NCT01371019
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The following is a listing of all TREETOP (NCT02787213) IRBs. All IRBs gave approval. IRB for Human Research Medical University of South Carolina Office of Human Research Ethics The University of North Carolina at Chapel Hill Maricopa Integrated Health System IRB Oregon Health & Science University IRB University of Texas Medical Branch IRB Boston Medical Center IRB Ochsner Clinic Foundation IRB University of California, San Diego Human Research Protections Program Northwestern University IRB Indiana University IRB Duke Medicine IRB for Clinical Investigations Greenville Health System IRB Western IRB (used by Denver Health & Hospital Authority, University of Colorado-Denver, UC-Irvine, Thomas Jefferson University, Regional Obstetrical Consultants, and Baystate Medical Center) The following is a listing of all PAPR (NCT01371019) IRBs. All IRBs gave approval. Institutional Review Board for Human Research, Office of Research Integrity, Medical University of South Carolina Office of Human Research Ethics, University of North Carolina Maricopa Integrated Health System Institutional Review Board Baystate Medical Center Institutional Review Board Research Integrity Office, Oregon Health Sciences University University of Texas Medical Branch Institutional Review Board Christiana Care Institutional Review Board Western IRB (used by Ohio State University, San Diego Perinatal Center, Regional Obstetrical Consultants)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data generated for this manuscript is available by contacting info@seraprognostics.com
